Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021

Carlo Casanovaa Swiss National Reference Center for Invasive Pneumococci (NZPn), Institute for Infectious Diseases, University of Bern, Bern, Switzerland;b Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandView further author information

Marianne Küffera Swiss National Reference Center for Invasive Pneumococci (NZPn), Institute for Infectious Diseases, University of Bern, Bern, Switzerland;b Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandView further author information

Stephen L. Leiba Swiss National Reference Center for Invasive Pneumococci (NZPn), Institute for Infectious Diseases, University of Bern, Bern, Switzerland;b Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandView further author information

Markus Hiltya Swiss National Reference Center for Invasive Pneumococci (NZPn), Institute for Infectious Diseases, University of Bern, Bern, Switzerland;b Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandCorrespondence[email protected]

https://orcid.org/0000-0002-2418-6474 View further author information

Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021

Supplementary_tablefigures_R1_vf.docx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021

Supplementary_tablefigures_R1_vf.docx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date